Recombinant Vibrio splendidus UPF0208 membrane protein VS_0999 (VS_0999) is a protein derived from the bacterium Vibrio splendidus. It belongs to the UPF0208 family of proteins and is characterized as a membrane protein. The "recombinant" aspect indicates that this protein is produced using recombinant DNA technology, typically in a host organism like E. coli .
Recombinant VS_0999 is produced in E. coli and often includes an N-terminal His tag to facilitate purification . The protein is stored in a Tris/PBS-based buffer with 6% Trehalose to maintain stability. It is recommended to avoid repeated freeze-thaw cycles and to store the protein at -20°C or -80°C for long-term storage .
VS_0999 is a member of the UPF0208 protein family, which currently has unknown function. As a multi-pass membrane protein located in the cell's inner membrane, it is likely involved in transport processes, signal transduction, or maintaining membrane integrity.
As a recombinant protein, VS_0999 can be used in various research applications:
Structural Studies: To determine the three-dimensional structure of the protein, which can provide insights into its function.
Functional Assays: To investigate the protein's role in Vibrio splendidus, possibly through in vitro assays or by studying the effects of its deletion or overexpression in the organism.
Antibody Development: To generate antibodies that specifically target VS_0999, which can be used for detection or therapeutic purposes.
KEGG: vsp:VS_0999
STRING: 575788.VS_0999
KEGG: vsp:VS_0999
STRING: 575788.VS_0999
For optimal stability and experimental reproducibility when working with VS_0999 protein, follow these research-validated protocols:
Storage protocol:
Store the lyophilized protein at -20°C/-80°C upon receipt
After reconstitution, make working aliquots to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
For long-term storage, add glycerol (typically to a final concentration of 50%) and store at -20°C/-80°C
Reconstitution protocol:
Briefly centrifuge the vial prior to opening to ensure all material is at the bottom
Reconstitute in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
The protein is typically supplied in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0
Note that repeated freeze-thaw cycles significantly reduce protein activity and should be strictly avoided in experimental workflows.
Investigating the membrane topology of VS_0999 requires a multi-faceted experimental approach:
Computational prediction: Begin with topology prediction algorithms (TMHMM, TOPCONS) to identify potential transmembrane segments.
Proteolytic digestion mapping: Use techniques like:
Limited proteolysis with proteases like trypsin or chymotrypsin on intact cells or spheroplasts
Compare digestion patterns using Western blotting with antibodies against different domains or the His tag
Cysteine scanning mutagenesis: Systematically replace amino acids with cysteine and use membrane-permeable and impermeable thiol-reactive reagents to determine which residues are accessible from which side of the membrane.
Fluorescence-based approaches:
GFP-fusion reporter approach, attaching GFP to different positions in the protein
FRET analysis between strategically placed fluorophores
Structural analysis: For definitive topology determination, techniques like:
Cryo-electron microscopy
X-ray crystallography if the protein can be solubilized and crystallized
Based on recent advances in membrane protein research, computational design approaches could also be applied to create soluble analogues of VS_0999, which might retain key structural features while being more amenable to structural studies .
To effectively study VS_0999 protein-protein interactions, consider these methodological approaches:
Co-immunoprecipitation (Co-IP):
Express VS_0999 with an epitope tag (His tag is already present)
Perform pull-down assays followed by mass spectrometry to identify interacting partners
Validate using reciprocal Co-IP with antibodies against identified partners
Bacterial two-hybrid system:
Adapt bacterial two-hybrid systems for membrane proteins
Use split-ubiquitin yeast two-hybrid system specifically designed for membrane proteins
Construct a prey library from V. splendidus genomic DNA
Crosslinking approaches:
Chemical crosslinking with membrane-permeable crosslinkers
Photo-crosslinking with photo-activatable amino acid analogues incorporated into VS_0999
Analysis of crosslinked complexes by mass spectrometry
Fluorescence-based methods:
FRET between VS_0999 labeled with one fluorophore and potential partners labeled with another
Bimolecular Fluorescence Complementation (BiFC)
Fluorescence Correlation Spectroscopy (FCS) for dynamic interactions
Functional assays:
Bacterial growth assays in the presence of antibiotics or stress conditions
Virulence assays using cellular models
Expression analysis of downstream genes in VS_0999 knockout strains vs. wild-type
When analyzing data, be aware that membrane protein interactions often show high background and may require stringent controls. Comparison of results across multiple methods is strongly recommended.
Investigating VS_0999's role in pathogenicity requires a comprehensive approach combining genetic manipulation, functional assays, and infection models:
Gene knockout and complementation:
Generate a clean VS_0999 deletion mutant using allelic exchange
Create a complemented strain by reintroducing VS_0999 under a native or inducible promoter
Develop point mutants targeting key functional residues predicted by structural analysis
Virulence assessment in infection models:
Challenge appropriate host organisms (e.g., larvae) with wild-type, knockout, and complemented strains
Assess mortality rates, tissue damage, and bacterial loads in infected tissues
Monitor disease progression through histopathological analysis
Based on previous research with pathogenic V. splendidus strains, the following experimental parameters can be used:
| Parameter | Wild-type strain | VS_0999 knockout (hypothetical) | Complemented strain |
|---|---|---|---|
| Larval mortality (24h at 10⁶ CFU/mL) | 79-88% | Expected reduction if VS_0999 is involved in virulence | Should restore wild-type levels |
| Bacterial recovery from infected larvae | 9.59×10⁴-2.08×10⁵ bacteria/g | Expected reduction | Should restore wild-type levels |
| Time to first clinical signs | <24 hours | Expected delay | Should restore wild-type timing |
Analysis of virulence factor expression:
Host response analysis:
Measure host immune response markers
Evaluate tissue damage markers
Assess metabolic changes in host during infection
Transcriptomic/proteomic analysis:
RNA-seq comparison between wild-type and VS_0999 mutant
Proteomic analysis of membrane fractions
Identification of differentially regulated pathways
To explore antagonistic relationships between VS_0999 and probiotic Vibrio strains, a systematic approach combining molecular, biochemical, and functional analyses is recommended:
Growth inhibition assays:
Co-culture V. splendidus expressing VS_0999 with potential probiotic Vibrio strains (e.g., Vibrio sp. V33)
Measure growth inhibition through OD600 measurements
Perform spot assays on solid media to visualize growth inhibition zones
Analysis of antagonistic substances:
Fractionate cell-free supernatants from probiotic strains:
Test fractions for inhibitory activity against V. splendidus expressing VS_0999
Characterize active fractions by mass spectrometry
Proteomic and expression analysis:
Real-time RT-PCR monitoring:
Design primers targeting VS_0999 and related functional genes
Monitor expression changes after exposure to probiotic supernatants
Use the comparative threshold cycle method (2^-ΔΔCT) for analysis
Based on previous research on antagonistic relationships between Vibrio strains, consider this experimental setup for real-time RT-PCR:
| Time point after exposure | Gene expression measurement | Internal control |
|---|---|---|
| 10 minutes | VS_0999, fur, asbJ, viuB | 16S rRNA |
| 20 minutes | VS_0999, fur, asbJ, viuB | 16S rRNA |
| 30 minutes | VS_0999, fur, asbJ, viuB | 16S rRNA |
Promoter analysis:
For comprehensive protein-protein interaction (PPI) network mapping of membrane proteins like VS_0999, a multi-method approach addressing the challenges of membrane protein biochemistry is required:
Proximity-dependent labeling methods:
BioID: Fuse VS_0999 to a promiscuous biotin ligase (BirA*) that biotinylates proximal proteins
APEX2: Fuse VS_0999 to an engineered ascorbate peroxidase that catalyzes biotinylation of proximal proteins
These methods allow in vivo labeling of interactors in their native membrane environment
Membrane-specific interactomics:
Detergent-based membrane solubilization optimization
Blue-native PAGE coupled with second-dimension SDS-PAGE
Gradient centrifugation to isolate membrane protein complexes
Crosslinking mass spectrometry (XL-MS):
Use membrane-permeable crosslinkers with different spacer arm lengths
Analyze crosslinked peptides by LC-MS/MS
Apply computational pipelines specific for membrane protein XL-MS data analysis
Quantitative interactomics:
SILAC or TMT labeling for quantitative comparison of interactomes
Compare wild-type vs. VS_0999 mutant strains
Statistical analysis to identify high-confidence interactions
Computational network integration:
Integrate experimental data with genomic context methods
Apply Bayesian integration of multiple data types
Use machine learning approaches to predict additional interactions
When analyzing interaction data, follow this workflow:
| Analysis step | Method | Expected outcome |
|---|---|---|
| Primary filtering | Statistical significance testing | High-confidence direct interactors |
| Network construction | Graph-based algorithms | Functional modules and complexes |
| Functional annotation | GO enrichment, pathway analysis | Biological processes involving VS_0999 |
| Validation | Targeted biochemical assays | Confirmation of key interactions |
| Integration | Meta-analysis with published data | Placement in cellular pathways |
This integrated approach helps overcome the challenges of false positives common in membrane protein interaction studies while providing a comprehensive view of VS_0999's functional network.
When investigating VS_0999's effects on bacterial growth and virulence, a robust experimental design must address several critical factors:
Expression system optimization:
Evaluate constitutive vs. inducible promoters
Titrate expression levels to avoid artifacts from overexpression
Confirm proper membrane localization using fractionation and Western blotting
Consider native vs. tagged versions and validate tag effects
Growth condition variables:
Test multiple growth media compositions, particularly varying iron availability
Examine growth across different temperatures relevant to host and environmental conditions
Assess stationary phase vs. logarithmic phase effects
Include various stress conditions (pH, salt concentration, antimicrobial compounds)
Statistical design considerations:
Use appropriate sample sizes based on power analysis
Include biological replicates (minimum n=3) and technical replicates
Implement randomization and blinding where possible
Use paired experimental designs when comparing isogenic strains
Virulence model selection:
Choose appropriate infection models based on V. splendidus ecology:
Larval challenge assays with relevant host species
Cell culture infection models
Ex vivo tissue models
Consider bacterial inoculum standardization methods:
OD-based vs. CFU-based standardization
Growth phase standardization
Pre-adaptation to host conditions
Molecular phenotyping approaches:
Transcriptomics (RNA-seq) with appropriate time points
Proteomics focused on secreted and membrane fractions
Metabolomics to capture small molecule profiles
Real-time monitoring using reporter systems
Based on published virulence studies with V. splendidus, consider this experimental design matrix:
| Variable factor | Levels to test | Measurement endpoints |
|---|---|---|
| Bacterial concentration | 10⁴, 10⁶, and 10⁸ CFU/mL | Mortality rates at 6, 12, 18, 24, 30, 36, and 48h |
| Host system | Minimum 3 relevant species | Species-specific clinical signs, bacterial recovery |
| Growth conditions | Standard, iron-limited, host-mimicking | Growth curves, virulence factor expression |
| VS_0999 expression | Wild-type, knockout, complemented, overexpressed | Transcriptional effects, protein levels, phenotypic outcomes |
Implement appropriate controls including:
Vehicle controls for expression inducers
Empty vector controls for recombinant expression
Sham operation controls for infection models
Measurement of VS_0999 expression levels across all experimental conditions
For predicting functional domains and binding sites in VS_0999 when experimental structures are unavailable, implement this comprehensive structural bioinformatics workflow:
Template-based modeling:
Perform sensitive sequence similarity searches using HHpred or HHsearch
Identify distant homologs with known structures in the PDB
Generate multiple sequence alignments for conservation analysis
Create homology models using tools like MODELLER or SWISS-MODEL
Validate models using MolProbity, PROCHECK, and QMEAN
Ab initio and deep learning approaches:
Apply AlphaFold2 or RoseTTAFold for accurate structure prediction
Generate multiple models and analyze structural convergence
Combine with template-based models for consensus predictions
Validate predictions using established metrics (pLDDT scores, PAE plots)
Membrane protein-specific considerations:
Predict transmembrane regions using TMHMM, TOPCONS, and MEMSAT
Apply membrane protein-specific modeling tools like MEMOIR
Position models correctly in the membrane using OPM database principles
Perform molecular dynamics simulations in explicit membrane environments
Functional site prediction:
Apply computational solvent mapping to identify potential binding pockets
Use ConSurf for evolutionary conservation mapping onto structural models
Implement machine learning-based binding site predictors (e.g., DeepSite)
Apply molecular docking with fragment libraries to probe binding preferences
Integration with experimental data:
Correlate structural features with sequence variants in multiple strains
Design targeted mutations for experimental validation
Use computational models to interpret experimental phenotypes
Refine models iteratively based on experimental outcomes
Recent research has demonstrated that deep learning-based approaches can design soluble analogues of membrane proteins while preserving key structural features . This strategy could be applied to VS_0999 to facilitate experimental structural studies while maintaining functionally important domains.
For VS_0999, focus analysis on:
Membrane-facing vs. solvent-exposed regions
Highly conserved surface patches across related species
Potential metal-binding sites
Regions with structural similarity to known functional domains in other proteins
Document your structural analysis findings in this format:
| Structural feature | Prediction method | Confidence score | Suggested experimental validation |
|---|---|---|---|
| Transmembrane regions | TMHMM, TOPCONS consensus | High for regions with >90% agreement | Cysteine scanning mutagenesis |
| Potential ligand binding site | ConSurf + SiteMap | Medium (conservation score >7) | Site-directed mutagenesis of key residues |
| Protein-protein interaction interface | SPPIDER, PrePPI | Low-Medium | Co-immunoprecipitation studies |
| Functional motifs | PROSITE, InterPro | Variable | Deletion or point mutation analysis |
Emerging technologies offer exciting opportunities to deepen our understanding of VS_0999's role in bacterial membrane biology:
Single-molecule techniques:
Single-molecule FRET to monitor conformational changes
Single-molecule force spectroscopy to measure binding forces
Super-resolution microscopy (PALM/STORM) to visualize VS_0999 organization in native membranes
These approaches can reveal dynamic behavior not accessible through bulk measurements
Cryo-electron tomography:
Visualize VS_0999 in its native membrane environment
Map spatial organization relative to other membrane components
Capture structural states under different conditions
Combine with subtomogram averaging for higher resolution
Deep mutational scanning:
Create comprehensive libraries of VS_0999 variants
Use high-throughput functional assays to assess each variant
Map sequence-function relationships at amino acid resolution
Identify critical functional residues and tolerant regions
Optogenetic approaches:
Engineer light-sensitive domains into VS_0999
Control protein activity with spatial and temporal precision
Study dynamic protein interactions in living cells
Monitor downstream signaling events in real-time
Integrative structural biology:
Combine computational prediction, crosslinking-MS, cryo-EM, and functional data
Generate comprehensive structural models across different functional states
Map allosteric networks and communication pathways
Apply molecular dynamics simulations in realistic membrane environments
Synthetic biology approaches:
Engineer minimal systems containing only essential components
Create orthogonal systems to study VS_0999 function in isolation
Design synthetic circuits to probe regulatory connections
Develop biosensors based on VS_0999 conformational changes
These emerging approaches could help address key questions about VS_0999, such as its potential roles in signaling, transport, or structural organization of the bacterial membrane.